A Nine-gene Signature Identified for Aggressive Prostate Cancers
David Olmos, Johann de Bono, first and senior authors respectively, Lancet Oct 2012—Study funded in part by PCF
Full Story

Protein Found in Prostate Cancer May Promote Cancer Growth and Progression
PCF-funding validates PARP1 as a good therapeutic target in prostate cancer
Full Story

New Data Shows Added Benefits for Prostate Cancer Drug Enzalutamide
New data adds to the arsenal of information on the effectiveness of enzalutamide
Full Story 

Read All October News 

National Proactive Surveillance Network (NPSN)
The Prostate Cancer Foundation, Johns Hopkins Medicine and Cedars-Sinai Medical Center announced the launch of the National Proactive Surveillance Network (NPSN), an online resource for men diagnosed with low-grade prostate cancer, which can be slow growing and non-life threatening in up to 50 percent of diagnosed cases. The network is structured to actively manage prostate cancer in patients who qualify for a non-intervening management program, known as proactive surveillance. Learn More

Movember

During November each year, Movember is responsible for the sprouting of moustaches on thousands of men’s faces, in the US and around the world. With their Mo's, these men and their Mo Sistas raise vital awareness and funds for prostate cancer research globally. Register Here

Read All October Spotlights 

Read Dan's October blog post,"The Mo' the Merrier," where he asks those who complain about the lack of blue vs. pink, "Why aren't you growing a Mo' for Movember?"